ArticleThe oncologist2026

Patient-reported time toxicity with bispecific antibody therapies in relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma.

Ajay Major et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.